Akela Pharma Awarded Development Contract from Pear Tree Pharmaceuticals, Inc. at its PharmaForm Subsidiary

www.bioportfolio.co.uk | Jun 15, 2008

Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory

http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=1583811&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=1583811&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz1455817098%26amp%3bz%3d950242273&THEHOST=site+d.moreover.com

Akela Pharma Inc. Initiates Its First Abuse Deterrent Opioid Phase I Clinical Trial

www.biospace.com | Mar 6, 2008

MONTREAL, March 6 /PRNewswire-FirstCall/ - Akela Pharma Inc. (TSX: "AKL"), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it has started its first EDACS(TM) product Phase I clinical trial.

http://www.biospace.com/news_story.aspx?StoryID=88375&full=1

Akela Pharma initiates its first abuse deterrent opioid Phase I clinical trial

www.prnewswire.com | Mar 6, 2008

The study will be carried out in 12 healthy subjects, and the results are expected to be available in Q3/2008. "The abuse of prescription drugs is approaching epidemic proportions in numerous countries. The costs to society associated with this abuse are tremendous.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/03-06-2008/0004768856&EDATE=

Genetics & Environmental Business Week (2005-10-20) | NewsRx

- Phase 1 trial for asthma product successful completion announced Landauer, Inc. - William E. Saxelby elected president, CEO of radiation detection service company Lariboisiere Hospital, Paris - Researchers provide details of new studies and findings in the area of thrombosis LifeSensors Inc.

http://www.newsrx.com/newsletters/Genetics-and-Environmental-Business-Week/2005-10-20.html